{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:08:07Z","timestamp":1789610887568,"version":"build-2803163510"},"reference-count":34,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160039"],"award-info":[{"award-number":["82160039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82560035"],"award-info":[{"award-number":["82560035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Guangxi Province","award":["2025GXNSFAA069052"],"award-info":[{"award-number":["2025GXNSFAA069052"]}]},{"name":"Open Research Project from Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education","award":["GXGXLCJYZDX2025007"],"award-info":[{"award-number":["GXGXLCJYZDX2025007"]}]},{"name":"Middle-aged and Young Teachers\u2019 Basic Ability Promotion Project of Guangxi","award":["2024KY0112"],"award-info":[{"award-number":["2024KY0112"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Acute myeloid leukemia (AML) is a hematological malignancy of the myeloid lineage with poor clinical outcomes due to limited targeted therapies. This study elucidates the role of inositol 1,4,5-trisphosphate receptor type 2 (ITPR2) in regulating cell apoptosis by modulating mitochondrial calcium (Ca2+) levels and underscores the clinical significance of ITPR2. Methods: ITPR2 expression in patients with AML compared with that of healthy controls using the quantitative real-time PCR (RT-qPCR) method. The role of ITPR2 in AML and its association with immune infiltration levels were investigated through bioinformatics analyses. ITPR2 knockdown in Tohoku Hospital Pediatrics-1 (THP-1) cells were achieved using small interfering RNA (siRNA) and 2-aminoethyl diphenylborinate (2-APB), followed by comprehensive molecular characterization employing RT-qPCR, western blotting (WB), cell counting kit-8 (CCK-8) assays, and flow cytometry. Results: ITPR2 was validated as being highly expressed in patients with AML, and this expression correlated with risk stratification and poor prognosis. Functional enrichment analysis revealed that ITPR2 is involved in Ca2+ signaling pathways and mitochondrial-related biological processes, and its expression level was negatively correlated with immune infiltration levels. Knockdown of ITPR2 or inhibition of its activity with 2-APB reduced Ca2+ ion concentrations in both the cytoplasm and mitochondria, leading to mitochondrial dysfunction (characterized by elevated intracellular reactive oxygen species (ROS) levels, reduced mitochondrial membrane potential (MMP) levels, and reduced mitochondrial DNA copy number) and eventually AML cell apoptosis. Conclusion: ITPR2 facilitates AML progression via the Ca2+-mitochondrial axis and may serve as a prognostic factor and potential therapeutic target.<\/jats:p>","DOI":"10.31083\/fbl47824","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:56:49Z","timestamp":1772279809000},"source":"Crossref","is-referenced-by-count":2,"title":["ITPR2 Promotes Acute Myeloid Leukemia Progression Through Calcium-Mediated Mitochondrial Dysfunction"],"prefix":"10.31083","volume":"31","author":[{"given":"Xiaoke","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"},{"name":"Key Laboratory of Hemotology, Guangxi Medical University, Education Department of Guangxi Zhuang Autonomous Region, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6499-6607","authenticated-orcid":true,"given":"Zhenfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. Journal of Hematology & Oncology. 2023; 16: 29.","DOI":"10.1186\/s13045-023-01424-6"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bohl SR, Bullinger L, R\u00fccker FG. New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise. International Journal of Molecular Sciences. 2019; 20: 1983.","DOI":"10.3390\/ijms20081983"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ando H, Kawaai K, Bonneau B, Mikoshiba K. Remodeling of Ca2+ signaling in cancer: Regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors. Advances in Biological Regulation. 2018; 68: 64\u201376.","DOI":"10.1016\/j.jbior.2017.12.001"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Parys JB, Bultynck G, Vervliet T. IP3 Receptor Biology and Endoplasmic Reticulum Calcium Dynamics in Cancer. Progress in Molecular and Subcellular Biology. 2021; 59: 215\u2013237.","DOI":"10.1007\/978-3-030-67696-4_11"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Han B, Zhen F, Zheng XS, Hu J, Chen XS. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. BMC Cancer. 2022; 22: 297.","DOI":"10.1186\/s12885-022-09410-w"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ueasilamongkol P, Khamphaya T, Guerra MT, Rodrigues MA, Gomes DA, Kong Y, et al. Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma. Hepatology (Baltimore, Md.). 2020; 71: 583\u2013599.","DOI":"10.1002\/hep.30839"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, et al. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Human Molecular Genetics. 2012; 21: 456\u2013462.","DOI":"10.1093\/hmg\/ddr479"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wu W, Shi Z, Tang Z, Li H, Huang X, Liang X, et al. Characterization of bone marrow heterogeneity in NK-AML (M4\/M5) based on single-cell RNA sequencing. Experimental Hematology & Oncology. 2023; 12: 25.","DOI":"10.1186\/s40164-023-00391-5"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Shi JL, Fu L, Wang WD. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia. Oncotarget. 2015; 6: 5299\u20135309.","DOI":"10.18632\/oncotarget.3024"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"MacCannell D, Berger Z, Kirschner J, Mercuri E, Farrar MA, Iannaccone ST, et al. Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model. CNS Drugs. 2022; 36: 181\u2013190.","DOI":"10.1007\/s40263-022-00899-0"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Yang S, Hui TL, Wang HQ, Zhang X, Mi YZ, Cheng M, et al. High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer. World Journal of Clinical Cases. 2023; 11: 4788\u20134799.","DOI":"10.12998\/wjcc.v11.i20.4788"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lima AS, Bezerra MF, Moreira-Aguiar A, Weinh\u00e4user I, Santos BL, Falc\u00e3o RM, et al. Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained setting. Hematology, Transfusion and Cell Therapy. 2024; 46: 250\u2013255.","DOI":"10.1016\/j.htct.2023.04.005"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013; 39: 782\u2013795.","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Danilova L, Ho WJ, Zhu Q, Vithayathil T, De Jesus-Acosta A, Azad NS, et al. Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival. Cancer Immunology Research. 2019; 7: 886\u2013895.","DOI":"10.1158\/2326-6066.CIR-18-0822"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zhao Q, Wang Q, Wang T, Xu J, Li T, Liu Q, et al. Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma. Frontiers in Immunology. 2021; 12: 765615.","DOI":"10.3389\/fimmu.2021.765615"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Tsang SM, Kim H, Oliemuller E, Newman R, Boateng NA, Guppy N, et al. Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells. Disease Models & Mechanisms. 2021; 14: dmm046037.","DOI":"10.1242\/dmm.046037"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Qian X, Wang Y, Liu Z, Fang F, Ma Y, Zhou L, et al. Establishment of XRD fourier fingerprint identification method of realgar decoction pieces and its anti-tumor activity in tumor-in-situ transplanted mice. Journal of Ethnopharmacology. 2024; 331: 118303.","DOI":"10.1016\/j.jep.2024.118303"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Moradi A, Abdihaji M, Kouchaksaraie SB, Alkinani TA, Mahmoudi A, Davoudi A, et al. Synthesize of Bi2O3\/Gln-TSC nanoparticles and evaluation of their toxicity on prostate cancer cells and expression of CASP8, BAX, and Bcl-2 genes. Scientific Reports. 2022; 12: 21245.","DOI":"10.1038\/s41598-022-25360-6"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Gu W, Ma X, Yang C, Jiang D, Fan H, Wang L, et al. Insight into Ca2+- inositol 1,4,5-trisphosphate receptor 2 (IP3R2)-mediated unfolded protein response and apoptosis in scallop Patinopecten yessoensis under high temperature stress. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 2025; 278: 111092.","DOI":"10.1016\/j.cbpb.2025.111092"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Huang X, Jin M, Chen YX, Wang J, Zhai K, Chang Y, et al. ERP44 inhibits human lung cancer cell migration mainly via IP3R2. Aging. 2016; 8: 1276\u20131286.","DOI":"10.18632\/aging.100984"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhang N, Wu Y, Gong J, Li K, Lin X, Chen H, et al. Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population. Oncotarget. 2017; 8: 24196\u201324201.","DOI":"10.18632\/oncotarget.6917"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Akl H, Monaco G, La Rovere R, Welkenhuyzen K, Kiviluoto S, Vervliet T, et al. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death & Disease. 2013; 4: e632.","DOI":"10.1038\/cddis.2013.140"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Singh A, Chagtoo M, Tiwari S, George N, Chakravarti B, Khan S, et al. Inhibition of Inositol 1, 4, 5-Trisphosphate Receptor Induce Breast Cancer Cell Death Through Deregulated Autophagy and Cellular Bioenergetics. Journal of Cellular Biochemistry. 2017; 118: 2333\u20132346.","DOI":"10.1002\/jcb.25891"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang Y, Yang Y, Zhao D, Liu R, Li S, et al. Proteomic analysis of ITPR2 as a new therapeutic target for curcumin protection against AFB1-induced pyroptosis. Ecotoxicology and Environmental Safety. 2023; 260: 115073.","DOI":"10.1016\/j.ecoenv.2023.115073"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Liu G, Zhang Q, Yang J, Li X, Xian L, Li W, et al. Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis. Cancer Immunology, Immunotherapy: CII. 2022; 71: 277\u2013287.","DOI":"10.1007\/s00262-021-02978-5"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Zhang Q, Bi J, Zheng X, Chen Y, Wang H, Wu W, et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nature Immunology. 2018; 19: 723\u2013732.","DOI":"10.1038\/s41590-018-0132-0"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Huang S, Liang C, Zhao Y, Deng T, Tan J, Zha X, et al. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia. Cytometry. Part B, Clinical Cytometry. 2022; 102: 143\u2013152.","DOI":"10.1002\/cyto.b.22049"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Schnorfeil FM, Lichtenegger FS, Emmerig K, Schlueter M, Neitz JS, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. Journal of Hematology & Oncology. 2015; 8: 93.","DOI":"10.1186\/s13045-015-0189-2"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Bustos G, Ahumada-Castro U, Silva-Pavez E, Puebla A, Lovy A, Cesar Cardenas J. The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster. International Review of Cell and Molecular Biology. 2021; 363: 49\u2013121.","DOI":"10.1016\/bs.ircmb.2021.03.006"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Sheth AI, Althoff MJ, Tolison H, Engel K, Amaya ML, Krug AE, et al. Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium. Cancer Discovery. 2024; 14: 1922\u20131939.","DOI":"10.1158\/2159-8290.CD-23-1145"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Zhong W, Xu M, Li C, Zhu B, Cao X, Li D, et al. ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLC\u03b23 Catalysis: Targeting It Eradicates Leukemia Stem Cells. Cell Reports. 2019; 26: 2166\u20132177.e9.","DOI":"10.1016\/j.celrep.2019.01.082"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Monaco G, Percio S, Ting SB. Budgeting at the Ca2+ store: a PIP(2)eline to starve LSCs? Cell Calcium. 2021; 93: 102309.","DOI":"10.1016\/j.ceca.2020.102309"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Dubinin MV, Chulkov AV, Igoshkina AD, Cherepanova AA, Mikina NV. Effect of 2-aminoethoxydiphenyl borate on the functions of mouse skeletal muscle mitochondria. Biochemical and Biophysical Research Communications. 2024; 712\u2013713: 149944.","DOI":"10.1016\/j.bbrc.2024.149944"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM, Belous AE, et al. 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2007; 293: G623\u2013G630.","DOI":"10.1152\/ajpgi.00521.2006"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/2\/10.31083\/FBL47824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:56:54Z","timestamp":1772279814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/2\/10.31083\/FBL47824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)01984-2"],"URL":"https:\/\/doi.org\/10.31083\/fbl47824","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"47824"}}